When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ARQL - ArQule rallies after reporting blood cancer results
ArQule Inc.
ArQule (NASDAQ:ARQL) +35.9% pre-market after releasing preliminary results from its phase 1 dose escalation study for ARQ 531 demonstrates substantial anti-tumor activity and a favorable safety profile.
More news on: ArQule, Inc., Healthcare stocks news, Stocks on the move,